Garlic extract in prosthesis-related infections: a literature review

Abstract

With the increasing use of joint replacement surgery, the prevalence of periprosthetic joint infections (PJI) has also increased. However, treating PJI has become a challenge for orthopaedic surgeons because of the prevalence of multi-drug resistant (MDR) bacteria and the formation of protective biofilms. Numerous studies have shown that garlic extract (GE) has antibacterial activities and might be a good candidate for PJI treatment. This review explores the antibacterial and antibiofilm activities of GE and its potential to be used in the treatment of PJI.

Keywords

Garlic allicin ajoene multi-drug resistant bacteria methicillin-resistant Staphylococcus aureus biofilm periprosthetic joint infections

Introduction

Periprosthetic joint infection (PJI) is a serious complication for both patients and surgeons after total joint arthroplasty.^1,2 The prevalence of PJI after total hip arthroplasty and total knee arthroplasty is approximately 1% and 2%, respectively.^3,4 This complication may occur during the immediate postoperative period or even decades after surgery.^3,5 However, treating PJI remains a challenge even for an experienced orthopaedic surgeon due to the limitation of many factors. The most important reason is the prevalence of multi-drug resistant (MDR) bacteria, also known as ‘superbugs’, and the formation of bacterial biofilms, which significantly reduces the efficacy of antibiotics or even renders them ineffective.² Alternative treatments, therefore, especially for biofilm-associated infections need to be developed urgently.

Recently, some naturally occurring products have attracted widespread attention because of their antimicrobial properties or their ability to not induce drug resistance. Garlic is an example of such a naturally occurring compound. It has been reported that garlic extract (GE) has many biological activities including antibacterial,^6,7 antiviral,⁶ antifungal^6,8,9 and antiparasitic activities;¹⁰ especially anti-MDR bacterial and antibiofilm activities.^6,11,12 Additionally, with the development of drug-loaded nanoparticle technology,^13,14 the prospect of the clinical application of garlic extract has been greatly improved. This review explores the antibacterial and antibiofilm activities of GE and its potential to be used in the treatment of PJI.

Literature review search strategy

Searches of the PubMed and EMBASE (Elsevier platform) databases were performed independently by the authors (X.Z. and Y.Z.) in September 2019. Comprehensive strategies, including both Medical Subject Headings and terms, were used and publication date of articles was not restricted. The language was limited to English. In addition, a manual review of the full reference lists of relevant articles was undertaken. The PubMed database search was performed as follows: (“infection”[MeSH] OR Infection[Ti ab] OR Infections[Ti ab] OR Prosthesis-Related Infections[Ti ab] OR Prosthesis Related Infections[Ti ab] OR Infections, Prosthesis-Related[Ti ab] OR Prosthesis-Related Infection[Ti ab] OR periprosthetic Joint Infection[Ti ab] OR “PJI” [Ti ab] OR “biofilms”[MeSH] OR Biofilms[Ti ab] OR Biofilm[Ti ab] OR “bacterial adhesion”[MeSH] OR Bacterial Adhesion[Ti ab] OR Bacterial[Ti ab] OR Bacterial Adhesions[Ti ab]) AND (“garlic”[MeSH] OR Garlic[Ti ab] OR “allium”[MeSH] OR Allium[Ti ab] OR Alliaceae[Ti ab]). The same search strategy was used for the EMBASE database. The eligible articles were discussed and selected by the two authors.

The active ingredients of garlic and their biological characteristics

The two main active components of garlic are allicin and ajoene, with allicin playing the most prominent role.^13,15 Allicin (diallylthiosulphinate), a sulphur-containing naturally occurring compound, is produced by tissue damage that causes enzymatic reactions and it is responsible for the typical smell and taste of garlic.¹⁵Allicin has a variety of biological activities, including antimicrobial,^6,7,16 antibiofilm^12,13 and antifungal activities.^6,8,9,16 However, allicin is rapidly oxidized, volatile and unstable, so it breaks down rapidly as soon as the garlic is damaged, which is why allicin cannot be widely used.¹⁴

Fresh garlic extract (FGE) or garlic oil is more stable compared with allicin, due to the hydrogen bonding between water and the reactive oxygen atom, which increases the stability of allicin.⁶ Numerous studies have reported the good antimicrobial activity of water-based extract of FGE.^6,7

Ajoene, a sulphur-containing compound derived from allicin, is biologically active and more stable than allicin.¹⁷ Therefore, more and more researchers have begun to pay close attention to it and have demonstrated its ability to inhibit the quorum sensing (QS) system.^17,18

In addition, garlic compounds have also been shown to prevent cardiovascular disease,^19–23 decrease cholesterol and fatty acid levels,^24–26 reduce blood pressure,^23,25,27,28 regulate the immune system,^15,28 prevent and treat tumours,^15,29–31 and resist parasites.³² The similarities and differences between allicin and ajoene are shown in Table 1.

Table 1.

The similarities and differences between the two main components of garlic allicin and ajoene.

	Similarities	Differences
	Similarities	Chemical name	Biological activity	Smell	Content
Allicin	Sulphur-containing compoundDerived from garlicAntibacterial and antibiofilm effect	Diallylthiosulphinate	Unstable	Sour or spicy	High
Ajoene		4,5,9-trithiadodeca-1,6,11-triene-9-oxide	Stable	No distinctive smell	Low

Characteristics of prosthesis-related infections

As the number of total joint replacements increases, so does the risk of infection around the prosthesis.^2,3 PJI can be divided into bacterial and fungal infections according to the different pathogenic organisms involved. The main bacterial pathogens are Staphylococcus aureus and S. epidermidis,⁵ while the most common fungal pathogen is Candida albicans.³³ PJI can also be categorized based on the time period of the infection into an acute or chronic infection.³ Systemic antibiotic treatment is the main treatment strategy for acute infections, while the current gold standard of treatment for chronic infection is second-phase revision.³ Chronic infection is more common in the clinic, but the failure rate of its treatment remains high.² The most important cause of PJI is the emergence of MDR bacteria and the development of biofilms, resulting in poor or even ineffective antibiotic treatment.^2,3 Therefore, new drugs with a broad spectrum of antibacterial activity that can not only destroy biofilms but also kill resistant bacterial strains are needed urgently.

Antibacterial effect and related mechanism of GE

Garlic extract has a broad spectrum of antibacterial activity, which includes inhibiting or killing antibiotic-resistant strains of bacteria in a dose-dependent manner.³⁴ A study demonstrated that FGE exhibited significant inhibitory properties on methicillin-resistant S. aureus and C. albicans, while inhibition of Pseudomonas aeruginosa was weak.⁶ Another study also showed that pure garlic essential oil had a stronger antibacterial effect on Gram-positive bacteria than Gram-negative bacteria.³⁵ An in vitro study compared the antibacterial effect of fresh garlic juice on Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, P. aeruginosa and S. aureus, and it demonstrated S. aureus and E. coli were the most sensitive organisms.⁷ Another study reported the good antimicrobial activity of FGE against five MDR strains, which included E. coli, P. aeruginosa, K. pneumoniae, Serratia marcescens and MRSA.³⁶ These studies have demonstrated that FGE has extensive antibacterial activity, including against drug-resistant bacterial strains.^6,34–36

At present, studies on the specific antibacterial mechanism of GE are scarce. A study demonstrated that garlic essential oil had good antimicrobial activity against S. aureus, P. aeruginosa and E. coli, and that the allyl group was fundamental for this activity.³⁷ S. aureus responds to allicin by global S-thioallylation.³⁸ Another study showed that disulphide and vancomycin have synergistic effects against vancomycin-resistant S. aureus by causing dispersal of biofilms and decelerating the metabolism of S. aureus.³⁹ The authors suggested that pyridyl disulphide, representing a new class of antimicrobial agent with different antibacterial mechanisms, could be used as antibiotic adjuvants for vancomycin-resistant S. aureus infections.³⁹ The mechanisms of action of GE remain to be elucidated. The antibacterial effects and related mechanisms of action of GE are listed in Table 2.^{6,7,14,35–37,39,40}

Table 2.

Examples of the antibacterial activity and related mechanisms of action of various garlic extracts.^{6,7,14,35–37,39,40}

Author	Year	Compound	Bacteria	Experimental category	Mechanism of action
Cutler et al.⁴⁰	2004	Allicin liquids	Staphylococcus aureus and methicillin-resistant S. aureus	In vitro	Not mentioned
Farrag et al.³⁶	2019	Fresh garlic extract	Multi-drug resistant	In vitro and in vivo	Not mentioned
Piletti et al.¹⁴	2019	Garlic oil	S. aureus and Escherichia coli	In vitro	Not mentioned
Li et al.⁶	2015	Fresh garlic extract	Methicillin-resistant S. aureus, Pseudomonas aeruginosa and Candida albicans	In vitro	Not mentioned
Hasssanzadeh et al.³⁵	2018	Garlic essential oil	S. aureus and E. coli	In vitro	Not mentioned
Yadav et al.⁷	2015	Fresh garlicjuice	E. coli, Klebsiella pneumoniae, Proteus mirabilis, P. aeruginosa and S. aureus	In vitro	Not mentioned
Casella et al.³⁷	2013	Garlic essential oil	S. aureus, P. aeruginosa and E. coli	In vitro	The presence of the allyl group
Sheppard et al.³⁹	2018	Pyridyl disulphides	Vancomycin-resistant S. aureus	In vitro	Dispersed biofilms and decelerated metabolism of S. aureus

Antibiofilm effect and related mechanism of GE

The most prominent feature of PJI is the emergence of MDR bacteria and biofilms.^2,3 Due to the protection provided by the biofilm, the bacteria inside the biofilm are very difficult to kill.² Therefore, effectively destroying the biofilm becomes a key aim of the treatment of PJI. Many studies have shown that GE, as a naturally occurring antibacterial substance, has a good antibiofilm effect.^11,17,41,42 A previous study reported the eradication of biofilms of MDR bacteria.³⁶ Garlic ointment prevented biofilm formation of S. aureus, S. epidermidis, P. aeruginosa, Acinetobacter baumannii and K. pneumoniae.¹² In addition, the anti-staphylococcus activity of garlic ointment was very stable and could be maintained for more than 3 months at room temperature.¹²

There are many reports about allicin inhibiting bacterial adherence and preventing biofilm formation in vitro.^11,41,42 However, whether this property still works in vivo remains unknown. A previous study established an artificial knee joint infection model in rabbits and divided the rabbits into four groups, which were lavaged with normal saline, allicin, vancomycin or allicin plus vancomycin for 14 days.¹¹ The study demonstrated that intra-articular allicin could not only enhance the bactericidal effect of vancomycin but it also inhibited biofilm formation in vivo.¹¹ Therefore, the authors suggested that allicin combined with vancomycin might be an effective anti-infection strategy for the treatment of PJI.

The components of GE, such as allicin and ajoene, interfere with the formation of bacterial biofilm in multiple ways.^17,41–44 Among them, polysaccharide intercellular adhesin (PIA) and QS are the two most studied areas. For example, PIA (poly-β(1-6)-N-acetylglucosamine), which is a positively charged, partially deacetylated molecule, is an important component of the Gram-positive bacterial biofilm matrix network.⁴⁴ Subminimum inhibitor concentrations of allicin could not only reduce bacterial adhesion and extracellular polymeric substance secretion, but they could also inhibit the synthesis of PIA in S. epidermidis.⁴²

Quorum sensing, an information exchange system used by pathogenic bacteria, plays an important role in biofilm formation and disseminating bacteria to new infection sites.⁴⁵ Therefore, interfering with the QS system may be an effective measure for the treatment of biofilm-associated infection.⁴⁴ A previous study demonstrated that allicin extensively participated in downregulating the production of various virulence factors, such as exotoxin A, elastase and rhamnolipids, all of which are widely involved in QS.⁴¹ Through bioassay-guided fractionation of FGE, it was found that the primary QS inhibitor in garlic was ajoene.¹⁷Ajoene not only downregulated the gene expression involved in bacterial rhamnolipid synthesis and prevented the lysis of polymorphonuclear leukocytes so as to enhance the host immunity against infections, but it also downregulated the expression of small regulatory RNA molecules involved in the production of important QS virulence factors, such as chitinase, cytotoxic lectin and chitin binding protein.^17,43 Currently, the QS system remains the focus of research in the field of antibiofilm treatments. The antibiofilm effects and related mechanisms of action of GE are listed in Table 3.^{11–13,17,36,41,42}

Table 3.

Examples of the antibiofilm activity and related mechanisms of action of various garlic extracts.^{11–13,17,36,41,42}

Author	Year	Compound	Bacteria	Experimental category	Mechanism of action
Jakobsen et al.¹⁷	2012	Ajoene	Pseudomonas aeruginosa	In vitro and in vivo	Quorum sensing inhibitor through rhamnolipid; synergistic tobramycin against biofilm
Farrag et al.³⁶	2019	Fresh garlic extract	Multi-drug resistant	In vitro and in vivo	Not mentioned
Zhai et al.¹¹	2014	Allicin	Staphylococcus epidermidis	In vivo	Synergistic vancomycin against biofilm
Lihua et al.⁴¹	2013	Allicin	P. aeruginosa	In vitro	Inhibited bacterial adhesion; reduced extracellular polymeric substance secretion; down-regulated virulence factor production
Cruz-Villalon et al.⁴²	2011	Allicin	S. epidermidis	In vitro	Inhibited polysaccharide intercellular adhesion formation
Girish et al.¹³	2019	Nanoparticle system loaded with garlic extract	Methicillin-resistant Staphylococcus aureus	In vitro	Not mentioned
Nidadavolu et al.¹²	2012	Garlic ointment	S. aureus, S. epidermidis, P. aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae	In vitro	Not mentioned

Antifungal effect and related mechanism of GE

Compared with the antibacterial actions of GE, there are few studies on the antifungal actions of GE.^6,8,9,16,46 A previous study reported that GE had inhibitory properties on C. albicans.⁶ The antifungal mechanisms of GE mainly include the abilities to penetrate the cell membrane,⁹ destroy the cell structure and alter gene expression of microorganisms.^8,9 A previous study showed that garlic oil could destroy the cellular structure by penetrating into hyphae cells and their organelles, leading to the leakage of intracellular substances.⁸ It was also shown that garlic oil could exhibit antifungal effects by altering the expression of some crucial genes and proteins involved in normal metabolism, pathogenesis and oxidation-reduction processes.⁹

Development of a GE carrier

Although GE has strong antibacterial properties, it is easily degraded because of its susceptibility to oxidation, volatilization and heat.³⁵ There is a need to improve the stability and maintain the antibacterial performance of GE. A microencapsulation method that used β-cyclodextrin (βCD) to thermally protect garlic oil was developed.¹⁴ The garlic oil retained significant antibacterial properties after the thermal treatment of the βCD-garlic oil complexes.¹⁴ Meanwhile, βCD, a sugar structure, is non-toxic and can be completely absorbed. The authors suggested that βCD was a carrier that could enhance heat resistance, reduce volatility, provide protection from oxidation and increase the durability of the antibacterial properties of GE.¹⁴

Extracellular polymeric substances can inhibit the penetration of immune cells and antimicrobial agents into biofilms.¹³ Therefore, the survival abilities of bacteria inside biofilms would be, even in high concentrations of antibiotics, significantly improved.^2,3 The long-term exposure of bacteria to antibiotics increases the incidence of drug-resistant strains. The extracellular matrix is another substance that can influence therapeutic efficacy.⁴⁴ Additionally, the physicochemical and mechanical properties of the biofilm as well as the charge compatibility of the drug influence the outcomes of anti-infective treatment.¹³ Different bacterial biofilms have different characteristics, so different therapeutic measures should be selected in order to effectively penetrate the biofilms.^13,14 Therefore, the ideal drug is one that can not only penetrate a biofilm matrix but can also eradicate all of the bacteria within it. If a delivery system that had both properties could be developed then it will have broad applications.

A sol-gel based nanoparticle system has been developed and it not only penetrated the bacterial biofilm but it also delivered different types of therapeutic agent.¹³ The authors reported an excellent antibiofilm activity against MRSA with the GE loaded in nanoparticles (GE-np) in vitro.¹³Compared with GE and mupirocin, GE-np was more effective in killing MRSA and biofilm, probably because GE-np slowed down the degradation of GE and exposed it to the inner layers of the biofilm.¹³ The authors also demonstrated the advantages of a sol-gel nanoparticle system.¹³ First, surface charge, hydrophobicity and particle size could be manipulated in order to penetrate different biofilms.¹³ Secondly, different types of antibiotics could be loaded into the nanoparticles for different types of infections.¹³ Finally, the slow release of the loaded antimicrobial drugs allowed the drugs to be easily delivered to the inner layers of the biofilms, which significantly increased the antibacterial effect.¹³

Currently, precoating prostheses with antimicrobials is one of the important strategies for inhibiting bacterial adhesion and biofilm formation.² Therefore, GE-np coated prostheses could be developed in the future.¹³

The safety of GE

Although GE has already exhibited potentially antibacterial and antibiofilm activities both in vivo and in vitro, its toxicity is still a barrier against its clinical usefulness. In recent years, several researchers have reported on the safety of GE.^36,47,48 In order to assess the safety, different concentrations of GE were given to rats intraperitoneally for 38 days.⁴⁷ As the dose of GE increased, the levels of liver enzymes and serum creatinine also increased.⁴⁷ At the same time, the structure and function of related organs also began to be destroyed.⁴⁷ Therefore, it was concluded that GE was safe at low levels (250–350 mg/kg/day).⁴⁷ A separate study recommended that the safe dose of GE was 350 mg/kg.⁴⁸ Similarly to these previous studies, another study injected GE into the abdominal cavity of mice systemically infected with P. aeruginosa and MRSA at two different doses (either 100 or 200 mg/kg) for 7 days.³⁶ There were no significant changes in haematological and biochemical parameters, as well as the histological architecture of the organs.³⁶ Therefore, low doses of GE appear to be safe, but the specific threshold remains to be studied.

Difficulties about GE applied to PJI in the future

Research on the application of GE to PJI has made considerable progress. However, there are still many difficulties to be resolved, including the following questions: (i) how can the biological activity of GE be effectively maintained?; (ii) which administration of GE is more effective, local or systemic?; (iii) what are the pharmacokinetics of GE under different conditions of administration?; (iv) what kind of administration frequency would be more effective?

Conclusion

In conclusion, in view of the increasing prevalence of infections caused by MDR bacteria, new promising alternative antimicrobials should be developed as a priority. The antibacterial and antibiofilm activities of GE suggest wide clinical applications in the future. The evidence to date suggests that GE will be a promising candidate for the treatment of PJI, although more research is required.

Footnotes

Declaration of conflicting interest

The authors declare that there are no conflicts of interest.

Funding

This review article was supported by a grant from the High-Level University Construction Project of Guangzhou University of Chinese Medicine (no. A1-AFD018171Z11068).

ORCID iD

Xing-Yang Zhu

References

Alamanda

Springer

BD.

Perioperative and modifiable risk factors for periprosthetic joint infections (PJI) and recommended guidelines.

Curr Rev Musculoskelet Med 2018; 11: 325–331. DOI: 10.1007/s12178-018-9494-z.

van Vugt

TAG

Arts

Geurts

JAP.

Antibiotic-loaded polymethylmethacrylate beads and spacers in treatment of orthopedic infections and the role of biofilm formation. Front Microbiol 2019; 10: 1626. DOI: 10.3389/fmicb.2019.01626.

Kapadia

Berg

Daley

, et al. Periprosthetic joint infection. Lancet 2016; 387: 386–394. DOI: 10.1016/s0140-6736(14)61798-0.

Kurtz

Ong

Lau

, et al. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res 2010; 468: 52–56. DOI: 10.1007/s11999-009-1013-5.

Pulido

Ghanem

Joshi

, et al. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 2008; 466: 1710–1715. DOI: 10.1007/s11999-008-0209-4.

Deng

, et al. Fresh garlic extract enhances the antimicrobial activities of antibiotics on resistant strains in vitro. Jundishapur J Microbiol 2015; 8: e14814. DOI: 10.5812/jjm.14814.

Yadav

Trivedi

Bhatt

Antimicrobial activity of fresh garlic juice: an in vitro study.

Ayu 2015; 36: 203–207. DOI: 10.4103/0974-8520.175548.

Shi

Liang

, et al. Antifungal effect and mechanism of garlic oil on Penicillium funiculosum. Appl Microbiol Biotechnol 2014; 98: 8337–8346. DOI: 10.1007/s00253-014-5919-9.

Shi

Dai

, et al. Antifungal activity, kinetics and molecular mechanism of action of garlic oil against Candida albicans. Sci Rep 2016; 6: 22805. DOI: 10.1038/srep22805.

10.

Argüello-García

de la Vega-Arnaud

Loredo-Rodríguez

, et al. Activity of thioallyl compounds from garlic against Giardia duodenalis trophozoites and in experimental giardiasis. Front Cell Infect Microbiol 2018; 8: 353. DOI: 10.3389/fcimb.2018.00353.

11.

Zhai

Pan

Pang

, et al. Lavage with allicin in combination with vancomycin inhibits biofilm formation by Staphylococcus epidermidis in a rabbit model of prosthetic joint infection. PLoS One 2014; 9: e102760. DOI: 10.1371/journal.pone.0102760.

12.

Nidadavolu

Amor

Tran

, et al. Garlic ointment inhibits biofilm formation by bacterial pathogens from burn wounds. J Med Microbiol 2012; 61: 662–671. DOI: 10.1099/jmm.0.038638-0.

13.

Girish

Liang

Aguilan

, et al. Anti-biofilm activity of garlic extract loaded nanoparticles. Nanomedicine 2019; 20: 102009. DOI: 10.1016/j.nano.2019.04.012.

14.

Piletti

Zanetti

Jung

, et al. Microencapsulation of garlic oil by β-cyclodextrin as a thermal protection method for antibacterial action. Mater Sci Eng C Mater Biol Appl 2019; 94: 139–149. DOI: 10.1016/j.msec.2018.09.037.

15.

Borlinghaus

Albrecht

Gruhlke

, et al. Allicin: chemistry and biological properties. Molecules 2014; 19: 12591–12618. DOI: 10.3390/molecules190812591.

16.

Fratianni

Riccardi

Spigno

, et al. Biochemical characterization and antimicrobial and antifungal activity of two endemic varieties of garlic (Allium sativum L.) of the Campania Region, Southern Italy. J Med Food 2016; 19: 686–691. DOI: 10.1089/jmf.2016.0027.

17.

Jakobsen

van Gennip

Phipps

, et al. Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing. Antimicrob Agents Chemother 2012; 56: 2314–2325. DOI: 10.1128/AAC.05919-11.

18.

Silva

Khokhar

Williams

, et al. Short total synthesis of ajoene. Angew Chem Int Ed Engl 2018; 57: 12290–12293. DOI: 10.1002/anie.201808605.

19.

Chan

Yuen

Chan

, et al. A review of the cardiovascular benefits and antioxidant properties of allicin. Phytother Res 2013; 27: 637–646. DOI: 10.1002/ptr.4796.

20.

Khatua

Adela

Banerjee

SK.

Garlic and cardioprotection: insights into the molecular mechanisms.

Can J Physiol Pharmacol 2013; 91: 448–458. DOI: 10.1139/cjpp-2012-0315.

21.

Mukherjee

Lekli

Goswami

, et al. Freshly crushed garlic is a superior cardioprotective agent than processed garlic. J Agric Food Chem 2009; 57: 7137–7144. DOI: 10.1021/jf901301w.

22.

Banerjee

Dinda

Manchanda

, et al. Chronic garlic administration protects rat heart against oxidative stress induced by ischemic reperfusion injury. BMC Pharmacol 2002; 2: 16.

23.

Stabler

Tejani

Huynh

, et al. Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients. Cochrane Database Syst Rev 2012; 8: Cd007653. DOI: 10.1002/14651858.CD007653.pub2.

24.

Abramovitz

Gavri

Harats

, et al. Allicin-induced decrease in formation of fatty streaks (atherosclerosis) in mice fed a cholesterol-rich diet. Coron Artery Dis 1999; 10: 515–519.

25.

Ali

Al-Qattan

Al-Enezi

, et al. Effect of allicin from garlic powder on serum lipids and blood pressure in rats fed with a high cholesterol diet. Prostaglandins Leukot Essent Fatty Acids 2000; 62: 253–259. DOI: 10.1054/plef.2000.0152.

26.

Eilat

Oestraicher

Rabinkov

, et al. Alteration of lipid profile in hyperlipidemic rabbits by allicin, an active constituent of garlic. Coron Artery Dis 1995; 6: 985–990.

27.

Ried

Frank

Stocks

, et al. Effect of garlic on blood pressure: a systematic review and meta-analysis. BMC Cardiovasc Disord 2008; 8: 13. DOI: 10.1186/1471-2261-8-13.

28.

Ried

Garlic lowers blood pressure in hypertensive individuals, regulates serum cholesterol, and stimulates immunity: an updated meta-analysis and review.

J Nutr 2016; 146: 389S–396S. DOI: 10.3945/jn.114.202192.

29.

Hirsch

Danilenko

Giat

, et al. Effect of purified allicin, the major ingredient of freshly crushed garlic, on cancer cell proliferation. Nutr Cancer 2000; 38: 245–254. DOI: 10.1207/s15327914nc382_14.

30.

Bat-Chen

Golan

Peri

, et al. Allicin purified from fresh garlic cloves induces apoptosis in colon cancer cells via Nrf2. Nutr Cancer 2010; 62: 947–957. DOI: 10.1080/01635581.2010.509837.

31.

Miron

Wilchek

Sharp

, et al. Allicin inhibits cell growth and induces apoptosis through the mitochondrial pathway in HL60 and U937 cells. J Nutr Biochem 2008; 19: 524–535. DOI: 10.1016/j.jnutbio.2007.06.009.

32.

Ankri

Miron

Rabinkov

, et al. Allicin from garlic strongly inhibits cysteine proteinases and cytopathic effects of Entamoeba histolytica. Antimicrob Agents Chemother 1997; 41: 2286–2288.

33.

Hwang

Yoon

Nam

, et al. Fungal peri-prosthetic joint infection after primary total knee replacement. J Bone Joint Surg Br 2012; 94: 656–659. DOI: 10.1302/0301-620X.94B5.

34.

El-Sayed

Chizzola

Ramadan

, et al. Chemical composition and antimicrobial activity of garlic essential oils evaluated in organic solvent, emulsifying, and self-microemulsifying water based delivery systems. Food Chem 2017; 221: 196–204. DOI: 10.1016/j.foodchem.2016.10.052.

35.

Hasssanzadeh

Alizadeh

Rezazad Bari

Formulation of garlic oil-in-water nanoemulsion: antimicrobial and physicochemical aspects.

IET Nanobiotechnol 2018; 12: 647–652. DOI: 10.1049/iet-nbt.2017.0104.

36.

Farrag

Hosny

AEMS

Hawas

, et al. Potential efficacy of garlic lock therapy in combating biofilm and catheter-associated infections; experimental studies on an animal model with focus on toxicological aspects. Saudi Pharm J 2019; 27: 830–840. DOI: 10.1016/j.jsps.2019.05.004.

37.

Casella

Leonardi

Melai

, et al. The role of diallyl sulfides and dipropyl sulfides in the in vitro antimicrobial activity of the essential oil of garlic, Allium sativum L., and leek, Allium porrum L. Phytother Res 2013; 27: 380–383. DOI: 10.1002/ptr.4725.

38.

Loi

Huyen

NTT

Busche

, et al. Staphylococcus aureus responds to allicin by global S-thioallylation – Role of the Brx/BSH/YpdA pathway and the disulfide reductase MerA to overcome allicin stress. Free Radic Biol Med 2019; 139: 55–69. DOI: 10.1016/j.freeradbiomed.2019.05.018.

39.

Sheppard

McAleer

Saralkar

, et al. Allicin-inspired pyridyl disulfides as antimicrobial agents for multidrug-resistant Staphylococcus aureus. Eur J Med Chem 2018; 143: 1185–1195. DOI: 10.1016/j.ejmech.2017.10.018.

40.

Cutler

Wilson

Antibacterial activity of a new, stable, aqueous extract of allicin against methicillin-resistant Staphylococcus aureus.

Br J Biomed Sci 2004; 61: 71–74. DOI: 10.1080/09674845.2004.11732646.

41.

Lihua

Jianhui

Jialin

, et al. Effects of allicin on the formation of Pseudomonas aeruginosa biofilm and the production of quorum-sensing controlled virulence factors. Pol J Microbiol 2013; 62: 243–251.

42.

Cruz-Villalon

Perez-Giraldo

. Effect of allicin on the production of polysaccharide intercellular adhesin in Staphylococcus epidermidis. J Appl Microbiol 2011; 110: 723–728. DOI: 10.1111/j.1365-2672.2010.04929.x.

43.

Jakobsen

Warming

Vejborg

, et al. A broad range quorum sensing inhibitor working through sRNA inhibition. Sci Rep 2017; 7: 9857. DOI: DOI: 10.1038/s41598-017-09886-8.

44.

Arciola

Campoccia

Ravaioli

, et al. Polysaccharide intercellular adhesin in biofilm: structural and regulatory aspects. Front Cell Infect Microbiol 2015; 5: 7. DOI: 10.3389/fcimb.2015.00007.

45.

Bhardwaj

Vinothkumar

Rajpara

Bacterial quorum sensing inhibitors: attractive alternatives for control of infectious pathogens showing multiple drug resistance.

Recent Pat Antiinfect Drug Discov 2013; 8: 68–83.

46.

Leontiev

Hohaus

Jacob

, et al. A comparison of the antibacterial and antifungal activities of thiosulfinate analogues of allicin. Sci Rep 2018; 8: 6763. DOI: 10.1038/s41598-018-25154-9.

47.

Fowotade

Enaibe

, et al. Evaluating toxicity profile of garlic (Allium sativum) on the liver, kidney and heart using Wistar rat model. Int J Trop Dis Health 2017; 26: 1–12. DOI: 10.9734/ijtdh/2017/36282.

48.

Lawal

Shittu

Oibiokpa

, et al. Antimicrobial evaluation, acute and sub-acute toxicity studies of Allium sativum. J Acute Dis 2016; 5: 296–301. DOI: 10.1016/j.joad.2016.05.002.